Senzime launches TetraCom platform to stream anesthesia data into major hospital IT systems

Senzime AB ( (SE:SEZI) ) just unveiled an update.

Senzime AB has introduced TetraCom, a hospital connectivity platform that transmits real-time neuromuscular data from its TetraGraph monitor directly into major electronic health record systems, including Epic and Oracle Health. The solution combines a compact hardware gateway with a cloud-based software layer using HL7 messaging to deliver wireless, cost-effective interoperability without bespoke integration work.

By eliminating manual charting and enabling automated, guideline-compliant documentation, TetraCom is positioned to improve workflow efficiency and data quality for anesthesia teams. Initially launched in the U.S. market, the platform strengthens Senzime’s connectivity offering and supports its push to derive additional value from perioperative data, potentially reinforcing its competitive position in digital operating room solutions.

The most recent analyst rating on (SE:SEZI) stock is a Sell with a SEK4.50 price target. To see the full list of analyst forecasts on Senzime AB stock, see the SE:SEZI Stock Forecast page.

More about Senzime AB

Senzime AB is a Swedish medical device company specializing in precision-based perioperative monitoring systems that enhance patient safety and reduce healthcare costs. Its flagship TetraGraph system provides best-in-class monitoring of neuromuscular transmission during surgery, supporting accurate dosing of paralytic drugs and is deployed in thousands of operating rooms globally.

Average Trading Volume: 223,481

Technical Sentiment Signal: Strong Sell

Current Market Cap: SEK693.3M

Learn more about SEZI stock on TipRanks’ Stock Analysis page.